The store will not work correctly when cookies are disabled.
5-chloro-2-(2-chloro-6-fluorophenyl)-2,3-dihydroquinazolin-4(1H)-one
ID: ALA5204703
PubChem CID: 164880750
Max Phase: Preclinical
Molecular Formula: C14H9Cl2FN2O
Molecular Weight: 311.14
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1NC(c2c(F)cccc2Cl)Nc2cccc(Cl)c21
Standard InChI: InChI=1S/C14H9Cl2FN2O/c15-7-3-1-5-9(17)11(7)13-18-10-6-2-4-8(16)12(10)14(20)19-13/h1-6,13,18H,(H,19,20)
Standard InChI Key: LRNRPLFSBRYMGJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
-2.5001 -0.2083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7833 -0.6166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0727 -0.2046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0727 0.6210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7851 1.0332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5001 0.6206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3577 1.0338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3577 1.8595 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.3573 0.6210 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3573 -0.2046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3577 -0.6174 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.7851 1.8588 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1.0724 -0.6175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7876 -0.2048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5001 -0.6171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5001 -1.4430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7894 -1.8552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0724 -1.4467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7876 0.6208 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
0.3573 -1.8595 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 2 0
9 7 1 0
10 9 1 0
11 10 1 0
3 11 1 0
5 12 1 0
10 13 1 0
14 13 2 0
15 14 1 0
16 15 2 0
17 16 1 0
18 17 2 0
13 18 1 0
14 19 1 0
18 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 311.14 | Molecular Weight (Monoisotopic): 310.0076 | AlogP: 3.99 | #Rotatable Bonds: 1 |
Polar Surface Area: 41.13 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.01 | CX Basic pKa: ┄ | CX LogP: 4.40 | CX LogD: 4.40 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.84 | Np Likeness Score: -1.01 |
References
1. Shishodia S, Nuñez R, Strohmier BP, Bursch KL, Goetz CJ, Olp MD, Jensen DR, Fenske TG, Ordonez-Rubiano SC, Blau ME, Roach MK, Peterson FC, Volkman BF, Dykhuizen EC, Smith BC.. (2022) Selective and Cell-Active PBRM1 Bromodomain Inhibitors Discovered through NMR Fragment Screening., 65 (20.0): [PMID:36227159] [10.1021/acs.jmedchem.2c00864] |